NCT03384511 2018-02-20The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.Shandong Cancer Hospital and InstitutePhase 4 Completed38 enrolled